What is NMN and Is It Safe with Blood Pressure Medications?
NMN (nicotinamide mononucleotide) is a precursor to NAD+ that appears safe to take with blood pressure medications based on available evidence, though you should be aware of a potential modest blood pressure-lowering effect that could theoretically enhance the effects of your BP medications.
What is NMN?
NMN is a molecule that your body converts into NAD+ (nicotinamide adenine dinucleotide), a critical coenzyme involved in over 400 enzymatic reactions including energy metabolism, DNA repair, and cellular stress responses 1. It's related to niacin (vitamin B3) but is a distinct compound - specifically, it's a metabolite that appears in urine as N-methyl-nicotinamide (NMN) when niacin is broken down 1.
Safety Profile
General Safety
Multiple clinical trials demonstrate that NMN is well-tolerated in healthy adults:
- Doses up to 1,250 mg daily for 4 weeks showed no adverse effects on vital signs, laboratory parameters, or body composition 2
- 250 mg daily for 12 weeks caused no abnormalities in physiological or laboratory tests 3
- Intravenous administration did not affect electrocardiograms, pulse, blood pressure, or metabolic markers 4
- EFSA safety evaluation concluded that up to 300 mg/day is safe for adults (excluding pregnant/lactating women), with a conversion factor to nicotinamide that remains well below the upper limit of 900 mg/day 5
Interaction with Blood Pressure Medications
The key consideration: NMN may modestly lower blood pressure, particularly diastolic pressure.
A 2026 meta-analysis of 10 randomized controlled trials found 6:
- Diastolic BP reduction: -2.15 mmHg (statistically significant)
- Systolic BP reduction in adults ≥60 years: -3.94 mmHg (statistically significant)
- Overall systolic BP reduction was not significant in younger adults
Clinical implications:
- This modest BP-lowering effect is unlikely to cause clinically significant hypotension when combined with BP medications in most patients
- However, if you're already well-controlled or prone to low blood pressure, monitor for symptoms of hypotension (dizziness, lightheadedness, fatigue)
- The effect is small enough that it shouldn't require medication adjustment in most cases, but awareness is prudent
Important Caveats
Cardiovascular considerations:
- One animal study showed that while NMN improved dyslipidemia and fatty liver, it promoted atherosclerosis in ApoE knockout mice at doses of 300 mg/kg, though lower doses (~100 mg/kg) had minimal harmful effects 7
- This raises theoretical concerns for individuals with existing cardiovascular disease, though human data has not confirmed this risk
- If you have established atherosclerotic disease, discuss this with your physician before starting NMN
Metabolic effects:
- NMN significantly reduces triglycerides 4
- May improve insulin sensitivity and walking capacity 8
- Increases in NAD+ levels are highly variable between individuals (coefficient of variation 29-113%) 8
Practical Recommendations
Dosing:
- Standard supplement doses range from 250-900 mg daily 9
- Take with or without food 9
- The EFSA considers up to 300 mg/day safe for long-term use 5
Monitoring if taking with BP medications:
- Check your blood pressure regularly for the first few weeks after starting NMN
- Watch for symptoms of low blood pressure (dizziness upon standing, fatigue, weakness)
- No need to adjust BP medications preemptively, but be prepared to discuss with your physician if you notice consistent BP drops
Who should avoid or use caution:
- Pregnant or lactating women (insufficient safety data) 9, 5
- Individuals under 18 years 9
- Those with established atherosclerotic cardiovascular disease should discuss with their physician first (based on animal data) 7
- Individuals prone to hypotension or on multiple BP medications may need closer monitoring
Drug interactions: The evidence does not show direct pharmacological interactions with antihypertensive medications 10. The concern is purely additive blood pressure lowering, not a drug-drug interaction that would alter medication metabolism or efficacy.